CPA Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$260K Hold
2,061
0.08% 92
2026
Q1
$287K Hold
2,061
0.1% 83
2025
Q4
$253K Hold
2,061
0.09% 92
2025
Q3
$229K Buy
2,061
+19
+0.9% +$2.16K 0.09% 83
2025
Q2
$226K Hold
2,042
0.1% 80
2025
Q1
$229K Buy
+2,042
New +$211K 0.1% 78

Other funds holding GILD

CPA Asset Management's GILD Position: Q2 2026 in Review

CPA Asset Management held its Gilead Sciences (GILD) position steady in Q2 2026 at 2,061 shares worth $260K. The position accounts for 0.08% of the portfolio, ranked #92.

CPA Asset Management first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. The position peaked at $287K in Q1 2026. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • CPA Asset Management held 2,061 shares of Gilead Sciences worth $260K as of Q2 2026.
  • CPA Asset Management left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.08% of CPA Asset Management's portfolio in Q2 2026, its #92 holding.
  • CPA Asset Management first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
  • CPA Asset Management's Gilead Sciences position peaked at $287K in Q1 2026.
  • 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on CPA Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.